Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB IN STK11/LKB1 LUNG CANCER POPULATION

The article identifies the key role of AXL inhibition in restoring response to immune checkpoint blockade therapy in lung cancer with mutations in the STK11/LKB1 gene   Bergen, Norway – 17 March 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, today announces the publication of a peer-reviewed article entitled “AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8+ T cells” in the journal Cell Reports Medicine.   The article

NoHo Partners Plc's Financial Statements, Corporate Governance Statement and Remuneration Report 2021 published

NoHo Partners PlcSTOCK EXCHANGE RELEASE 17 March 2022 at 9:15 a.m.NoHo Partners Plc's Financial Statements, Corporate Governance Statement and Remuneration Report 2021 published NoHo Partners Plc's Financial Statements and Report of the Board of Directors, auditor’s report, Corporate Governance Statement and Remuneration Report for the financial period that ended on 31 December 2021 have been published today on 17 March 2022. NoHo Partners Plc published its financial statements for the first time as an XHTML file compliant with the reporting requirements of the European Single

Enfo Group’s financial statement bulletin January 1 – December 31, 2021

Enfo 2021: Stable performance reinforced with new strategyQ4/2021 · Net sales in October-December were EUR 27.5 (26.8) million · EBITDA was EUR 2.1 (2.7) million · EBIT was EUR 0.0 (0.3) million · Profit for the period was EUR -0.5 (0.1) million · Earnings per share were EUR -0.6 (-1.5) · Operating cash flow was EUR 2.2 (1.9) million   Full-year 2021 · Net sales in 2021 were EUR 103.9 (101.5) million · EBITDA was EUR 7.4 (7.7) million · EBIT was EUR -2.3 (-1.5) million · Profit for the period was EUR -3.9 (-2.7) million · Earnings per share were

Share Options to Incentivise Long Term Performance

17 March 2022 IOG plc Grant of Share Options to Incentivise Long-Term Performance IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, announces that, under its Company Share Option Plan, it has today granted options over, in aggregate, 4,700,614 1p Ordinary Shares in the Company ("Ordinary Shares") to its executive directors, senior management and all employees to incentivise long-term performance (the "LTIP Options"). Following staff departures, the total net new LTIP issuance is 268,917 options as 4,431,

HusCompagniet generates more than DKK 4.3 billion in revenue for 2021 and deliver strong margins in a challenging market

Company announcement 12/2022 HusCompagniet sets new sales record with an increase of 24% of houses sold in 2021, which has been driven by an extraordinary high demand in H1 2021. Deliveries also increased with 12% to 1,831 houses. The increases have both been the highest in Group history. Reported revenue was DKK 4,315 million for 2021 corresponding to 20% growth from the revenue of 2020. EBITDA before special items increased by 16% to DKK 401 million corresponding to a margin of 9.3%. The overall performance of HusCompagniet has been satisfactory despite challenging markets.   "I’m

Settlement of patent litigation for Ultomiris

17 March 2022 07:00 GMT AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomiris Alexion, AstraZeneca's Rare Disease group, has entered into a settlement agreement with Chugai Pharmaceutical Co., Ltd. (Chugai), resolving all patent disputes between the two companies related to Ultomiris (ravulizumab). In accordance with the settlement agreement, Alexion and Chugai have taken steps to withdraw patent infringement proceedings filed with US District Court for the District of Delaware and Tokyo District Court.  Marc Dunoyer, Chief Executive Officer,

Konftel Announces Global Award Winners

Collaboration endpoint specialist Konftel has announced a series of global award winners, in tribute to some of its top performing distribution partners.Each year Konftel highlights its key distributors around the world with a special accolade, spanning best partners and largest growth, across different territories. The company says 2021 saw a continuing expansion and strengthening of relationships, as part of a dedicated ‘channel only’ route to market.  Director of Global Sales, Tommy Edlund, believes Konftel is ideally placed to help resellers and their customers in the continuing

BERGENBIO TO PRESENT AT CARNEGIE VIRTUAL NORDIC HEALTHCARE SEMINAR

Bergen, Norway, 17 March 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, is pleased to announce that CEO Martin Olin will be presenting at the Carnegie Virtual Nordic Healthcare Seminar taking place today at 15:15 CET. The presentation will be made available on the Company’s website in the Investors section shortly after the presentation. -Ends- Contacts  Martin OlinChief Executive Officer, BerGenBio ASAir@bergenbio.com   Rune SkeieChief Financial Officer,

Final Results for the Year Ended 31 December 2021

17 March 2022 IOG plc Final Audited Results for the Year Ended 31 December 2021 IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, is pleased to announce its final audited results for the Year Ended 31 December 2021. 2021 Highlights Corporate and Operational ·Phase 1 Blythe and Southwark normally unmanned platform installations were mechanically completed in April 2021 and safely installed at their offshore field locations in May-June 2021  ·Elgood well 48/22c-7 was successfully completed in

Attendo publishes Annual Report and Sustainability Report for 2021

Attendo's annual report for 2021 describes a year in which operations have gradually returned to normal after the corona pandemic, with an increased customer inflow and a renewed focus on developing methods that strengthen health and quality of life among customers. The report also presents a new framework for Attendo's sustainability work, which in the coming years will be integrated with the business strategy.The new framework is based on a sustainability agenda that has been developed after extensive internal work to be more clearly linked to Attendo's overall business strategy and

Synsam named Sweden’s most sustainable brand in optical retail for the fourth year in a row

Swedish consumers have named Synsam the most sustainable brand in optical retail, according to the annual Swedish brand survey by Sustainable Brand Index™ which was presented today. It is the fourth year in a row that Synsam receives this recognition for its efforts within sustainability.Synsam Group has a clear vision of being the leading and most sustainable lifestyle company in optical retail and eye health. This is achieved through a customer-driven approach, through offering sustainable choices and through taking responsibility for a sustainable climate and societal development. –

Skanska divests rental residential project in Stockholm, Sweden, for about SEK 580M

Skanska has divested a multi-family rental project with high climate ambitions in Stockholm, Sweden, for about SEK 580M. The buyer is NREP. The transaction will be recorded by Skanska Sweden in the Residential Development stream in the first quarter of 2022. The transfer will take place in connection with completion, which is planned for the first quarter of 2025.Skanska is developing the Tora project, next to Spånga commuter train station, in the emerging new Bromstensstaden. The block consists of 145 rental apartments, of which ten are LSS homes for people with special needs. There will

UNION therapeutics announces full year results for 2021 with significant advancement of the clinical pipeline, expansion of international collaborations and strengthening of the organization

Hellerup, Denmark, 17 March 2022 – UNION therapeutics A/S (“UNION”), a privately held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious diseases, announces the full year results for the period 1 January to 31 December 2021.     2021 has been a year of great progress for UNION with significant advancement to the clinical pipeline by successful development of the two lead molecules, orismilast and niclosamide, with the overall aim to develop best-in-class and first-in-class treatments within immunological and infectious diseases. UNION

Notice to the Annual General Meeting of NANOFORM FINLAND Plc

Notice to the Annual General Meeting of NANOFORM FINLAND Plc The shareholders of Nanoform Finland Plc (the “Company”) (business ID: 2730572-8) are hereby invited to the Annual General Meeting to be held on 12 April 2022 (EET) at 10:00am at Viikinkaari 4, FI-00790 Helsinki, Finland (“AGM”). The Board of Directors of the Company has resolved on the exceptional procedure for the meeting based on the temporary legislative act to limit the spread of the Covid-19 pandemic (375/2021). The Company has resolved to take actions enabled by the above-referred act in order to hold the meeting in a

EAB Group Plc publishes its Annual Report, Corporate Responsibility Report, Remuneration Report, Remuneration Policy and Corporate Governance Statement for 2021

EAB Group Plc, Stock Exchange Release, 17 March 2022, 9:00 a.m. (EET) EAB Group Plc publishes its Annual Report, Corporate Responsibility Report, Remuneration Report, Remuneration Policy and Corporate Governance Statement for 2021 EAB Group Plc has today, on 17 March 2022, published its Annual Report for 2021 on EAB Group's website at www.eabgroup.fi/sijoita-meihin/raportit-ja-esitykset. The Annual Report includes the Board of Directors’ report, the financial statements and the Auditor’s Report as well as the Corporate Governance Statement and the Corporate Responsibility Report.

Raisio plc: Notice to the Annual General Meeting

Raisio plc, Stock Exchange Release 17 March 2022   NOTICE TO THE ANNUAL GENERAL MEETING   Notice is given to the shareholders of Raisio plc of the Annual General Meeting, to be held on Tuesday 12 April 2022 at 2 p.m. EET at the company’s headquarters Raisionkaari 55, 21200 Raisio, Finland. The company’s shareholders may participate in the Annual General Meeting and exercise their shareholder rights only by voting in advance and by submitting counterproposals and asking questions in advance. It is not possible for the shareholders or their proxy representatives to participate

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release March 17, 2022 at 9:00 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on March 16, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on March 15, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+---------------

Raisio plc: Annual Review, Corporate Responsibility Report, Corporate Governance Statement and Remuneration Report published

Raisio plc, Stock Exchange Release, March 17, 2022 at 8.30 am EET Raisio plc’s Annual Review 2021 has been published today. The Annual Review includes the Financial Statements, the Consolidated Financial Statements, the report of the Board of Directors, the Auditor’s Report and Supervisory Board’s statement. For the financial year 2021, the company has also published its Corporate Responsibility Report. The Annual Review and the Corporate Responsibility Report are attached to this release and they are also available on the company’s web site https://www.raisio.com/en/investors/

Multiconsult ASA annual report 2021

ulticonsult ASA (OSE: MULTI)Today 17 March 2022 Multiconsult ASA publishes its annual report for 2021. Commencing in the 2021 annual and sustainability report in Multiconsult will be one integrated report with overview of priorities, measurements, and targets within environment, social and governance.The annual report is attached and available on the company’s website: https://www.multiconsult-ir.nohttps://www.multiconsult-ir.no, The company also publishes the annual report in European Single Electronic Format (ESEF), available as an attachment to this release. For further

The Nordic high yield market bound for another year of high activity

2021 was a fantastic year for the Nordic High Yield market with a record high issuance activity. Total issue volumes ended at EUR 6 billion – approximately 40% above the previous record from 2017. Market leader Pareto Securities is expecting another year with high activity in 2022.The Nordic high yield market is at a crossroad. The market that started as a substantial funding market for the capital-intensive energy sector in Norway has developed both in terms of industries and geographies and transitioned into a Norther European funding market for all kind of sectors. Ever more industries

Aker Clean Hydrogen AS: Notice of Annual General Meeting

The annual general meeting of Aker Clean Hydrogen AS will be held on Tuesday, 19 April 2022 at CET 1200 as a virtual meeting, where among other things election of new auditor is on the agenda.The meeting will be conducted as a virtual meeting only, accessible online via Lumi AGM. All shareholders will be able to participate in the meeting, vote and ask questions from smartphones, tablets or desktop devices. For further information regarding electronic participation, please refer to the guide available at www.akercleanhydrogen.com.  No pre-registration is needed for attending online, but

BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB IN STK11/LKB1 LUNG CANCER POPULATION

The article identifies the key role of AXL inhibition in restoring response to immune checkpoint blockade therapy in lung cancer with mutations in the STK11/LKB1 gene   Bergen, Norway – 17 March 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, today announces the publication of a peer-reviewed article entitled “AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8+ T cells” in the journal Cell Reports Medicine.   The article

Notice of Annual General Meeting in Multiconsult AS

Multiconsult (Oslo: MULTI)Annual general meeting of Multiconsult ASA will be held on 7 April 2022 at 05:00 p.m. (17:00) CET at the Company's main office, Nedre Skøyen vei 2, 0276 Oslo, Norway.This is a physical meeting, and we encourage shareholders to either participate by advance votes, proxy or physically. If any shareholder enrolled prefer to attend electronically, please send an e-mail to psmj@multiconsult.no and we will facilitate for this. All the documents to be processed at the annual general meeting, including the 2021 annual report, are available on the company's website

Vattenfall inaugurates new heat plant Carpe Futurum in Uppsala, Sweden

Vattenfall's new biofuel heat plant Carpe Futurum in Uppsala, Sweden, has now been inaugurated and taken into operation. The new plant will reduce carbon dioxide emissions by approximately 200,000 tonnes per year, compared with when peat and other fossil fuels were used. This will halve the climate footprint for the around 170,000 Uppsala residents who are connected to Vattenfall’s district heating grid in the city.“Carpe Futurum is a milestone in Vattenfall's work to phase out fossil fuels in its Swedish heat operation by 2025 and to reach net zero emissions within the entire company by

There are no items matching the current filter
There are no more items matching the current filter
Back to top